127 related articles for article (PubMed ID: 34077933)
1. A Preliminary Study of Deep-Learning Algorithm for Analyzing Multiplex Immunofluorescence Biomarkers in Body Fluid Cytology Specimens.
Yu W; Rao E; Chin CD; Aguilar-Jakthong JS; Li Y; Chow C; Wang SYG; Rao J
Acta Cytol; 2021; 65(4):348-353. PubMed ID: 34077933
[TBL] [Abstract][Full Text] [Related]
2. MOC31 Immunostaining in the Diagnosis of Metastatic Adenocarcinoma in Serous Fluid: Special Emphasis on Atypical Cytological Cases.
Sahu S; Sharma S; Gupta P; Dey P
Acta Cytol; 2021; 65(3):242-249. PubMed ID: 33827073
[TBL] [Abstract][Full Text] [Related]
3. Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology?
Lyons-Boudreaux V; Mody DR; Zhai J; Coffey D
Arch Pathol Lab Med; 2008 Jan; 132(1):23-8. PubMed ID: 18181669
[TBL] [Abstract][Full Text] [Related]
4. Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: a case report with brief review of immunomarkers.
Chowdhuri SR; Fetsch P; Squires J; Kohn E; Filie AC
Diagn Cytopathol; 2014 Mar; 42(3):253-8. PubMed ID: 23161830
[TBL] [Abstract][Full Text] [Related]
5. A fine decision tree consisted of CK5/6, IMP3 and TTF1 for cytological diagnosis among reactive mesothelial cells, metastatic adenocarcinoma of lung and non-lung origin in pleural effusion.
Yan J; Wei Q; Jian W; Liu J; Tang H; Ge J; Zhou J; Zhao T
Int J Clin Exp Pathol; 2014; 7(9):5810-8. PubMed ID: 25337222
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three commonly used cytologic preparations in effusion immunocytochemistry.
Fetsch PA; Simsir A; Brosky K; Abati A
Diagn Cytopathol; 2002 Jan; 26(1):61-6. PubMed ID: 11782091
[TBL] [Abstract][Full Text] [Related]
7. EZH2, a unique marker of malignancy in effusion cytology.
Jiang H; Gupta R; Somma J
Diagn Cytopathol; 2014 Feb; 42(2):111-6. PubMed ID: 23636867
[TBL] [Abstract][Full Text] [Related]
8. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA
Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174
[TBL] [Abstract][Full Text] [Related]
9. Cell transfer technique for constructing cytological microarrays for immunocytochemical analysis.
Wen CH; Lin CH; Ko PL; Kuo YF; Chen YJ; Chai CY
Cytopathology; 2017 Apr; 28(2):157-163. PubMed ID: 27526949
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of the EZH2 Immunomarker in Malignant Effusion Cytology.
Ang PP; Tan GC; Karim N; Wong YP
Acta Cytol; 2020; 64(3):248-255. PubMed ID: 31352449
[TBL] [Abstract][Full Text] [Related]
11. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
Su XY; Li GD; Liu HB; Jiang LL
Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
[TBL] [Abstract][Full Text] [Related]
12. Modified Liquid-Based Cytology Technique for Immunocytochemistry in Effusion Specimen.
Patarapadungkit N; Jangsiriwitayakorn P; Chaiwiriyakul S; Sirivech P; Thongbor R; Phanomsri EO; Nititarakul L
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2611-2617. PubMed ID: 31554354
[TBL] [Abstract][Full Text] [Related]
13. Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology.
Ko EC; Jhala NC; Shultz JJ; Chhieng DC
Am J Clin Pathol; 2001 Nov; 116(5):709-15. PubMed ID: 11710688
[TBL] [Abstract][Full Text] [Related]
14. Developing a Machine Learning Algorithm for Identifying Abnormal Urothelial Cells: A Feasibility Study.
Zhang Z; Fu X; Liu J; Huang Z; Liu N; Fang F; Rao J
Acta Cytol; 2021; 65(4):335-341. PubMed ID: 33022673
[TBL] [Abstract][Full Text] [Related]
15. Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens.
Ng WK; Chow JC; Ng PK
Cancer; 2002 Feb; 96(1):43-8. PubMed ID: 11836702
[TBL] [Abstract][Full Text] [Related]
16. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
Su XY; Li GD; Liu WP; Xie B; Jiang YH
Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
[TBL] [Abstract][Full Text] [Related]
17. Markers for metastatic adenocarcinoma in serous effusion specimens.
Shield PW; Callan JJ; Devine PL
Diagn Cytopathol; 1994; 11(3):237-45. PubMed ID: 7532566
[TBL] [Abstract][Full Text] [Related]
18. Use of cholesterol and soluble tumour markers CEA and syndecan-2 in pleural effusions in cases of inconclusive cytology.
Gulyas M; Fillinger J; Kaposi AD; Molnar M
J Clin Pathol; 2019 Aug; 72(8):529-535. PubMed ID: 31028099
[TBL] [Abstract][Full Text] [Related]
19. New diagnostic technique for rapid fluorescence immunocytochemical staining of adenocarcinoma and mesothelial cells using liquid-based cytology.
Morimoto A; Ito A; Hashimoto K; Nakano A; Nagasaka T; Yokoi T
Acta Cytol; 2014; 58(5):461-8. PubMed ID: 25358455
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of immunohistochemistry staining and cytologic diagnosis by using cell block sections prepared with effusion fluid cytology specimens].
Mao YY; Yang M; Liu DG; Lin MH; Zhang LQ; Chen ZQ
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):547-50. PubMed ID: 20021967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]